Skip to content

Prevention of minodronic acid on fracture at adjacent vertebral body following spinal fusion in osteoporotic patients

Prevention of minodronic acid on fracture at adjacent vertebral body following spinal fusion in osteoporotic patients - Prevention of minodronic acid on fracture at adjacent vertebral body following spinal fusion in osteoporotic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008714
Enrollment
200
Registered
2012-09-18
Start date
2012-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

The Minodolon acid hydrate administrated group The Minodolon acid hydrate non-administrated group

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: I decide to meet the following standards in a backbone fixation (or I form the vertebral body formation, a hunchback) art enforcement case 50 years or older. 1) A case to satisfy a version in osteoporotic diagnostic criteria 2000 by the bone metabolism society. 2) The case that enforced the backbone fixation (or I form the vertebral body formation, kyphosis) art due to a vertebral body bone fracture or the sliding symptom. 3) The case that was provided of the agreement.

Exclusion criteria

Exclusion criteria: 1) The impaired patient who delays stricture of the esophagus or the esophagus passage of a empty Shea (esophagus achalasia) 2) The patient who cannot wake up the upper part of the body at the time of remedy more than 30 minutes 3) Patient of the hypocalcemia 4) A pregnant woman or the woman who may be pregnant

Design outcomes

Primary

MeasureTime frame
New bone fracture of the adjacent vertebral body with X-rays

Secondary

MeasureTime frame
Bone density (if possible as for the bone density of the adjacent vertebral body) of the proximal thighbone by the DXA method, bone metabolism marker(urinary NTX), visual analog scale

Countries

Japan

Contacts

Public ContactBaba Hideo

Nagasaki University Hospital Orthopedics

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026